Intervention Review

Haemostatic drugs for traumatic brain injury

  1. Pablo Perel1,*,
  2. Ian Roberts1,
  3. Haleema Shakur1,
  4. Bandit Thinkhamrop2,
  5. Nakornchai Phuenpathom3,
  6. Surakrant Yutthakasemsunt4

Editorial Group: Cochrane Injuries Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 2 FEB 2009

DOI: 10.1002/14651858.CD007877.pub2

How to Cite

Perel P, Roberts I, Shakur H, Thinkhamrop B, Phuenpathom N, Yutthakasemsunt S. Haemostatic drugs for traumatic brain injury. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007877. DOI: 10.1002/14651858.CD007877.pub2.

Author Information

  1. 1

    London School of Hygiene & Tropical Medicine, Cochrane Injuries Group, London, UK

  2. 2

    Khon Kaen University, Department of Demography and Biostatistics, Khon Kaen, Thailand

  3. 3

    Prince of Songkla University, Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Hadyai, Songkla, Thailand

  4. 4

    Khon Kaen Regional Hospital, Khon Kaen, Thailand

*Pablo Perel, Cochrane Injuries Group, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.